SURG vs TNON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 31, 2026

SURG

45.3
AI Score
VS
SURG Wins

TNON

38.5
AI Score

Investment Advisor Scores

SURG

45score
Recommendation
HOLD

TNON

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric SURG TNON Winner
Forward P/E 3.3546 0 Tie
PEG Ratio 0.5333 0 Tie
Revenue Growth 40.7% 126.8% TNON
Earnings Growth -77.7% 0.0% TNON
Tradestie Score 45.3/100 38.5/100 SURG
Profit Margin -47.9% -257.9% SURG
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL SURG

Relative Price Performance (Last 90 Days)

SURG 1M: -23.4% · 3M: -72.0% TNON 1M: +2187.9% · 3M: +574.7%

Current Technical Phase

SURG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.6%), weak momentum, RSI 34

RSI (14): 34.4 · Price: $0.17

TNON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (404.7% over 20 days), RSI 52

RSI (14): 51.8 · Price: $4.53

Fundamentals Snapshot

Metric SURG TNON
Market Cap
Forward P/E 3.3 -0.4
Trailing P/E
Revenue (TTM)
Revenue Growth 0.4% 1.3%
Gross Margin -0.2% 0.7%
Operating Margin 0.2% -2.6%
EPS -1.49 -42.75
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SURG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.